Diagnosis Code E34.3
Information for Medical Professionals
The diagnosis code E34.3 is grouped in the following Diagnostic Related Group(s) (MS-DRG V35.0)
- 643 - ENDOCRINE DISORDERS WITH MCC
- 644 - ENDOCRINE DISORDERS WITH CC
- 645 - ENDOCRINE DISORDERS WITHOUT CC/MCC
Convert to ICD-9 General Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
- 259.4 - Dwarfism NEC
- Acquired partial lipodystrophy
- Asexual dwarfism
- Asexual dwarfism
- Autosomal recessive asexual dwarfism
- Congenital hypoplasia of gonad
- Constitutional short stature
- Disorder of tryptophan metabolism
- Dolichocephalic dwarfism
- Growth hormone receptor abnormality
- Growth hormone receptor absent
- Hypothyroid dwarfism
- Infantile dwarf
- Laron-type isolated somatotropin defect
- Lipodystrophy, partial, with Rieger anomaly, short stature, and insulinopenic diabetes mellitus
- Long narrow head
- Mental retardation, dwarfism, and gonadal hypoplasia due to xeroderma pigmentosa
- Multiple malformation syndrome, moderate short stature, facial
- Neurologic xeroderma pigmentosum
- Primordial dwarfism
- Senile dwarfism
- Short stature co-occurrent and due to endocrine disorder
- Tryptophanuria with dwarfism
- X-linked asexual dwarfism
Index of Diseases and Injuries
References found for the code E34.3 in the Index of Diseases and Injuries:
- Inclusion Terms: Inclusion terms
List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Constitutional short stature
- Laron-type short stature
- Type 1 Excludes Notes: Type 1 Excludes Notes
A type 1 Excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- achondroplastic short stature (Q77.4)
- hypochondroplastic short stature (Q77.4)
- nutritional short stature (E45)
- pituitary short stature (E23.0)
- progeria (E34.8)
- renal short stature (N25.0)
- Russell-Silver syndrome (Q87.1)
- short-limbed stature WITH "With"
The word "with" should be interpreted to mean "associated with" or "due to" when it appears in a code title, the Alphabetic Index, or an instructional note in the Tabular List. The word "with" in the Alphabetic Index is sequenced immediately following the main term, not in alphabetical order. immunodeficiency (D82.2)
- short stature in specific dysmorphic syndromes - code to syndrome - SEE "See"
The "see" instruction following a main term in the Alphabetic Index indicates that another term should be referenced. It is necessary to go to the main term referenced with the "see" note to locate the correct code. Alphabetical Index
- short stature NOS (R62.52)
Information for Patients
Does your child seem much shorter - or much taller - than other kids his or her age? It could be normal. Some children may be small for their age but still be developing normally. Some children are short or tall because their parents are.
But some children have growth disorders. Growth disorders are problems that prevent children from developing normal height, weight, sexual maturity or other features.
Very slow or very fast growth can sometimes signal a gland problem or disease.
The pituitary gland makes growth hormone, which stimulates the growth of bone and other tissues. Children who have too little of it may be very short. Treatment with growth hormone can stimulate growth.
People can also have too much growth hormone. Usually the cause is a pituitary gland tumor, which is not cancer. Too much growth hormone can cause gigantism in children, where their bones and their body grow too much. In adults, it can cause acromegaly, which makes the hands, feet and face larger than normal. Possible treatments include surgery to remove the tumor, medicines, and radiation therapy.
- Acromegaly (Medical Encyclopedia)
- Beckwith-Wiedemann syndrome (Medical Encyclopedia)
- Delayed growth (Medical Encyclopedia)
- Failure to thrive (Medical Encyclopedia)
- Gigantism (Medical Encyclopedia)
- Growth chart (Medical Encyclopedia)
- Growth hormone deficiency (Medical Encyclopedia)
- Growth hormone test (Medical Encyclopedia)
- Short stature (Medical Encyclopedia)
Laron syndrome Laron syndrome is a rare form of short stature that results from the body's inability to use growth hormone, a substance produced by the brain's pituitary gland that helps promote growth. Affected individuals are close to normal size at birth, but they experience slow growth from early childhood that results in very short stature. If the condition is not treated, adult males typically reach a maximum height of about 4.5 feet; adult females may be just over 4 feet tall.Other features of untreated Laron syndrome include reduced muscle strength and endurance, low blood sugar levels (hypoglycemia) in infancy, small genitals and delayed puberty, hair that is thin and fragile, and dental abnormalities. Many affected individuals have a distinctive facial appearance, including a protruding forehead, a sunken bridge of the nose (saddle nose), and a blue tint to the whites of the eyes (blue sclerae). Affected individuals have short limbs compared to the size of their torso, as well as small hands and feet. Adults with this condition tend to develop obesity. However, the signs and symptoms of Laron syndrome vary, even among affected members of the same family.Studies suggest that people with Laron syndrome have a significantly reduced risk of cancer and type 2 diabetes. Affected individuals appear to develop these common diseases much less frequently than their unaffected relatives, despite having obesity (a risk factor for both cancer and type 2 diabetes). However, people with Laron syndrome do not seem to have an increased lifespan compared with their unaffected relatives.